M. Buitron, “Doxorubicin-Induced Modulation of NF-κB, Bcl-2, and Bax Expression in Breast Cancer Cell Lines”., LACCEI, vol. 1, no. 12, Apr. 2025, doi: 10.18687/LACCEI2025.1.1.1649.